E
Kalaris Therapeutics, Inc. KLRS
$3.08 $0.5220.31% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Net Income -100.88% -199.27%
Total Depreciation and Amortization -- --
Total Amortization of Deferred Charges -100.00% -76.54%
Total Other Non-Cash Items 15.88% 31.95%
Change in Net Operating Assets -934.88% 213.01%
Cash from Operations -215.76% -64.59%
Capital Expenditure -- --
Sale of Property, Plant, and Equipment -- --
Cash Acquisitions -- --
Divestitures -- --
Other Investing Activities -- --
Cash from Investing -- --
Total Debt Issued -100.00% 50.21%
Total Debt Repaid -- --
Issuance of Common Stock -- --
Repurchase of Common Stock -- --
Issuance of Preferred Stock -- --
Repurchase of Preferred Stock -- --
Total Dividends Paid -- --
Other Financing Activities 100.00% 1,995,440.00%
Cash from Financing -100.00% 1,530.45%
Foreign Exchange rate Adjustments -- --
Miscellaneous Cash Flow Adjustments -- --
Net Change in Cash -1,339.03% 4,750.63%